NATHAN H THUMA
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- ANGWIN, CA
- NPI
- 1245316314
- Received
- $6,843 in 236 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 32 | $1,025 |
| 2024 | General payment | 36 | $1,340 |
| 2023 | General payment | 33 | $1,000 |
| 2022 | General payment | 33 | $775 |
| 2021 | General payment | 44 | $887 |
| 2020 | General payment | 23 | $426 |
| 2019 | General payment | 35 | $1,387 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 65 | $1,618 | 2020–2025 |
| Neurocrine BioSciences, Inc. | 56 | $1,404 | 2019–2025 |
| Alkermes, Inc. | 16 | $827 | 2019–2025 |
| ABBVIE INC. | 46 | $822 | 2021–2025 |
| Allergan, Inc. | 16 | $541 | 2019–2020 |
| Otsuka America Pharmaceutical, Inc. | 6 | $446 | 2019–2024 |
| Vanda Pharmaceuticals Inc. | 7 | $370 | 2019–2025 |
| Janssen Pharmaceuticals, Inc | 12 | $340 | 2019–2021 |
| BioXcel Therapeutics, Inc. | 2 | $149 | 2023 |
| Sunovion Pharmaceuticals Inc. | 1 | $120 | 2019 |
| E.R. Squibb & Sons, L.L.C. | 4 | $114 | 2025 |
| Indivior Inc. | 5 | $88 | 2019–2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 235 | $6,796 |
| Education | 1 | $46 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-09 | Vanda Pharmaceuticals Inc. | $146 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | E.R. Squibb & Sons, L.L.C. | $54 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-18 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-14 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-01 | Neurocrine BioSciences, Inc. | $139 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-16 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-26 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $108 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-05 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-22 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-26 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-17 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-20 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-26 | Alkermes, Inc. | $128 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-25 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-25 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-25 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-14 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-18 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-04 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-16 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-25 | Otsuka America Pharmaceutical, Inc. | $128 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-25 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-09-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-13 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-07 | Vanda Pharmaceuticals Inc. | $120 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-07-31 | Alkermes, Inc. | $119 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-07-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-16 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-07-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-05 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-05-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $137 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-08 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-05-07 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-24 | Alkermes, Inc. | $113 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-04-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-17 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-11 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-03-06 | Neurocrine BioSciences, Inc. | $136 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-02-27 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-02-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-30 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-01-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-09 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-01-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-02 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-12-12 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-05 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-14 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-31 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-31 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-09-19 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-14 | Alkermes, Inc. | $112 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-09-14 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $131 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-08-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-08-22 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-01 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-07-26 | BioXcel Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | IGALMI Drug, NEUROSCIENCE | 2023 | |
| 2023-07-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-07-11 | BioXcel Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | IGALMI Drug, NEUROSCIENCE | 2023 | |
| 2023-07-11 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-06 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-30 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-16 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-05-09 | Neurocrine BioSciences, Inc. | $139 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-04-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-18 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-04-04 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-23 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-09 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-28 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-28 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-02-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-01-10 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2022-12-15 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-12-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-11-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-11-03 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-25 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-10-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-10-18 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-09-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-09-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $118 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-09-20 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-09-01 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-08-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-08-16 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-07-26 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-07-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $7 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-07-05 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-06-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-05-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-05-24 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-05-10 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-04-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-04-26 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-04-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-04-05 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-03-15 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-03-01 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-02-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-02-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $112 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-02-01 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-01-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-01-18 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-01-18 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-01-04 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2021-12-14 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-12-08 | Alkermes, Inc. | $12 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-12-07 | Alkermes, Inc. | $9 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-12-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-11-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-11-30 | Alkermes, Inc. | $6 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-11-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-11-02 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-10-19 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2021 | |
| 2021-10-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-09-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-09-14 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-09-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-08-31 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-08-25 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VIIBRYD Drug, NEUROSCIENCE | 2021 | |
| 2021-08-24 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-08-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-08-04 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VIIBRYD Drug, NEUROSCIENCE | 2021 | |
| 2021-07-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-07-20 | Indivior Inc. | $14 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2021 | |
| 2021-07-09 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-24 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-06-15 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-06-08 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-06-02 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-04-28 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2021-04-27 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-04-20 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-04-01 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-03-16 | Indivior Inc. | $13 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2021 | |
| 2021-03-09 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-03-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-03-02 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2021 | |
| 2021-02-19 | Vanda Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2021 | |
| 2021-02-16 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-02-12 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2021 | |
| 2021-02-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-02-09 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-02-02 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-01-22 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2021 | |
| 2021-01-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2021 | |
| 2021-01-08 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-01-08 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2021 | |
| 2021-01-04 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2021 | |
| 2020-12-16 | Indivior Inc. | $20 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2020 | |
| 2020-12-15 | Allergan, Inc. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-11-25 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-11-03 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2020 | |
| 2020-11-03 | Allergan, Inc. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-10-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2020 | |
| 2020-10-13 | Allergan, Inc. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-10-13 | Allergan, Inc. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-09-18 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2020 | |
| 2020-09-08 | Allergan, Inc. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2020 | |
| 2020-08-27 | Allergan, Inc. | $41 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-05-15 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA TRINZA Drug, Neuroscience | 2020 | |
| 2020-03-03 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2020 | |
| 2020-02-28 | Allergan, Inc. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-02-25 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, NEUROLOGY | 2020 | |
| 2020-02-21 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2020 | |
| 2020-02-20 | Allergan, Inc. | $126 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-02-07 | Allergan, Inc. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 | |
| 2020-02-04 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA TRINZA Drug, Neuroscience | 2020 | |
| 2020-01-24 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2020 | |
| 2020-01-17 | Allergan, Inc. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2020 |
The latest 200 records of 236.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Angwin, CA, county Napa County, CA, state California; placed by its city name.
| Measure | Place (city or town) Angwin, CA | County Napa County, CA | State California |
|---|---|---|---|
| Population B01003 | 2,931 | 134,869 | 39,287,377 |
| Population, 2020 census P1 | 2,633 | 138,019 | 39,538,223 |
| Median age B01002 | 26.5 | 42.9 | 37.9 |
| Under 18 B01001 | 15.5% | 19.4% | 22.0% |
| 65 and over B01001 | 12.1% | 21.1% | 15.7% |
| Households B11001 | 844 | 49,763 | 13,548,091 |
| Foreign born B05002 | 16.9% | 22.2% | 27.0% |
| Median household income B19013 | $117,500 | $111,471 | $99,122 |
| Median family income B19113 | $152,609 | $137,457 | $113,346 |
| Per capita income B19301 | $51,940 | $61,040 | $49,513 |
| Poverty rate B17001 | 10.3% | 8.5% | 12.0% |
| Unemployment rate B23025 | 7.5% | 5.2% | 6.6% |
| Civilian labor force B23025 | 1,746 | 71,043 | 20,068,466 |
| Mean commute (minutes) B08013 | 17.4 | 24.9 | 28.7 |
| Bachelor's degree or higher B15003 | 50.2% | 39.8% | 37.1% |
| Housing units B25001 | 939 | 55,817 | 14,644,735 |
| Owner-occupied B25003 | 59.8% | 63.4% | 55.9% |
| Renters B25003 | 40.2% | 36.6% | 44.1% |
| Median home value B25077 | $708,100 | $869,500 | $734,700 |
| Median gross rent B25064 | $1,504 | $2,237 | $2,036 |
| White, not Hispanic B03002 | 49.5% | 48.6% | 33.8% |
| Black B03002 | 3.5% | 1.7% | 5.2% |
| Hispanic or Latino B03002 | 22.6% | 36.4% | 40.2% |
| Asian B03002 | 13.1% | 8.1% | 15.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Angwin, CA.
Comments